Prevent Blindness names September as sports eye safety awareness month

Article

Prevent Blindness has declared September as Sports Eye Safety Awareness Month in order to help educate the public on the importance of proper eye protection while playing sports.

Chicago-Prevent Blindness has declared September as Sports Eye Safety Awareness Month in order to help educate the public on the importance of proper eye protection while playing sports.

AOA warns against basketball-related eye injury

Sports-related eye injuries can range from corneal abrasions, inflamed iris, fracture of the eye socket, swollen or detached retinas, or even a traumatic cataract. And in some cases, a significant eye injury can cause permanent vision loss. For individuals with vision issues, especially those who can only see clearly or have limited vision through one eye, proper eye protection is even more essential.

“By taking the simple step of consistently wearing the proper eye protection today, we can help protect our vision for a lifetime,” said Hugh R. Parry, president and CEO of Prevent Blindness. “Today, there are different styles to choose from for any sport, including some that offer UV protection. We encourage everyone to consult their eyecare professional for the best advice on how to protect their eyes from injury.”

Prevent Blindness has once again joined with The Coalition to Prevent Sports Eye Injuries and Liberty Sport to provide eye care professionals with free information and materials through the “September is Sports Eye Injury Prevention Awareness Month” campaign.

Recent Videos
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.